What analyst predict for Allergan plc NYSE:AGN ?
Allergan plc NYSE:AGN
Allergan plc is stock market daily expected to report earnings on 04/30/2018 before market open. The report will be for the fiscal Quarter ending Mar 2018. According to stock market daily Investment Research, based on 23 analysts forecasts the consensus EPS forecast for the quarter is $3.36. The reported EPS for the same quarter last year was $3.35.
Overview of Allergan plc NYSE:AGN
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
|% Change from 52 Week Low|
|% Change from 52 Week High|